19-8302274-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016579.4(CD320):c.*189G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0596 in 756,224 control chromosomes in the GnomAD database, including 3,302 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 2028 hom., cov: 33)
Exomes 𝑓: 0.046 ( 1274 hom. )
Consequence
CD320
NM_016579.4 3_prime_UTR
NM_016579.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0440
Genes affected
CD320 (HGNC:16692): (CD320 molecule) This gene encodes the transcobalamin receptor that is expressed at the cell surface. It mediates the cellular uptake of transcobalamin bound cobalamin (vitamin B12), and is involved in B-cell proliferation and immunoglobulin secretion. Mutations in this gene are associated with methylmalonic aciduria. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-8302274-C-T is Benign according to our data. Variant chr19-8302274-C-T is described in ClinVar as [Benign]. Clinvar id is 1239139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.298 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD320 | NM_016579.4 | c.*189G>A | 3_prime_UTR_variant | 5/5 | ENST00000301458.10 | NP_057663.1 | ||
CD320 | NM_001165895.2 | c.*189G>A | 3_prime_UTR_variant | 4/4 | NP_001159367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD320 | ENST00000301458.10 | c.*189G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_016579.4 | ENSP00000301458 | P1 | ||
CD320 | ENST00000596002.5 | c.*1326G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ENSP00000471773 | ||||
CD320 | ENST00000537716.6 | c.*189G>A | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000437697 | ||||
CD320 | ENST00000599573.1 | downstream_gene_variant | 2 | ENSP00000471551 |
Frequencies
GnomAD3 genomes AF: 0.114 AC: 17370AN: 152098Hom.: 2020 Cov.: 33
GnomAD3 genomes
AF:
AC:
17370
AN:
152098
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0549 AC: 8506AN: 154816Hom.: 487 AF XY: 0.0513 AC XY: 4350AN XY: 84850
GnomAD3 exomes
AF:
AC:
8506
AN:
154816
Hom.:
AF XY:
AC XY:
4350
AN XY:
84850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0458 AC: 27681AN: 604008Hom.: 1274 Cov.: 7 AF XY: 0.0433 AC XY: 14097AN XY: 325296
GnomAD4 exome
AF:
AC:
27681
AN:
604008
Hom.:
Cov.:
7
AF XY:
AC XY:
14097
AN XY:
325296
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.114 AC: 17401AN: 152216Hom.: 2028 Cov.: 33 AF XY: 0.113 AC XY: 8430AN XY: 74428
GnomAD4 genome
AF:
AC:
17401
AN:
152216
Hom.:
Cov.:
33
AF XY:
AC XY:
8430
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
283
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at